Samsara BioCapital GP, LLC — SEC Form 4 filings
SEC reporting owner CIK 1888829. 7 Form 4 filings on record with FilingPulse; latest filed 2026-05-22.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-14 to 2026-05-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 9 legs across 6 filings — 2,222,472 shares, $28,037,590 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: purchase of 600,000 shares @ $13.50 ($8,100,000) in Mineralys Therapeutics, Inc., filed 2025-03-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | 10% owner | 2 | 2 legs · 1,155,555 sh · $15,599,992 | — | — |
| Kalaris Therapeutics, Inc. (KLRS) | 10% owner | 2 | 2 legs · 724,147 sh · $6,179,975 | — | 3 |
| CARGO Therapeutics, Inc. (CRGX) | 10% owner | 1 | 1 leg · 294,000 sh · $4,998,000 | — | — |
| Neurogene Inc. (NGNE) | 10% owner | 1 | 4 legs · 48,770 sh · $1,259,623 | — | — |
| vTv Therapeutics Inc. (VTVT) | 10% owner | 1 | — | — | 2 |
Form 4 filings — Samsara BioCapital GP, LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-22 | 4 | Kalaris Therapeutics, Inc. (KLRS) jointly with AKKARAJU SRINIVAS, Samsara BioCapital, L.P., Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC | Purchase (P): 244,300 @ $4.83 · Other (J): 66,906 @ $0 · Other (J): 14,937 @ $0 · Other (J): 4,471 @ $0 | EDGAR |
| 2026-02-17 | 4 | Kalaris Therapeutics, Inc. (KLRS) jointly with AKKARAJU SRINIVAS, Samsara BioCapital, L.P., Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC | Purchase (P): 479,847 @ $10.42 | EDGAR |
| 2025-03-17 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Samsara BioCapital, L.P. | Purchase (P): 600,000 @ $13.50 | EDGAR |
| 2024-12-06 | 4 | vTv Therapeutics Inc. (VTVT) jointly with Samsara BioCapital, L.P. | Other (J): 58,836 · Grant/award (A): 58,885 (derivative) | EDGAR |
| 2024-11-27 | 4 | Neurogene Inc. (NGNE) jointly with Samsara BioCapital, L.P., AKKARAJU SRINIVAS | Purchase (P): 20,748 @ $24.91 · Purchase (P): 10,803 @ $26.01 · Purchase (P): 15,219 @ $26.73 · Purchase (P): 2,000 @ $27.50 | EDGAR |
| 2024-06-03 | 4 | CARGO Therapeutics, Inc. (CRGX) jointly with Samsara BioCapital, L.P., AKKARAJU SRINIVAS | Purchase (P): 294,000 @ $17 | EDGAR |
| 2024-02-14 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Samsara BioCapital, L.P. | Purchase (P): 555,555 @ $13.50 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1888829 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →